STREPTOCOCCAL (GROUP A) INFECTION IN RUSSIA: STATE OF THE PROBLEM AND DEVELOPMENT TRENDS

Aim. To assess the current situation on streptococcal (group A) infection in Russia, to study the molecular properties and antimicrobial susceptibility of group A streptococcus isolated from patients with soft tissue infection.

Materials and methods. We performed a descriptive epidemiological study using official statistics. A total of 97 cases of soft tissue infection caused by group A streptococci were investigated for emm-types, the presence of genes of bacteriophage toxins and integrases by PCR and sequencing. We tested 91 strains for antimicrobial susceptibility by the micro dilution methods.

Results. From 2009 through 2017, 2.8 million cases (563 thousand primary cases) of group A streptococcal disease were reported. There was a decrease in the incidence of scarlet fever in Russia (31.5 per 100 000 population). In 2009–2017 the incidence of rheumatic fever and rheumatic heart diseases increase slightly but the prevalence of this forms group A streptococcal disease are decrease. Annually 2600 people die from the rheumatic fever and rheumatic heart diseases. Of the 97 cultures of group A streptococci, 33 were associated with invasive infection. We identified 33 different emm-type. All cultures contained speB gene. Some strains contained speA, and others speC genes. We did not find any correlation between the presence of bacteriophage toxin genes and the invasive properties of streptococci. Tetracycline and macrolides are ineffective in patients with of soft tissue infection

Conclusion. Streptococcal (group A) infection continues to be of significant social and economic importance for Russia. The streptococcus cultures isolated from patients with invasive forms were heterogeneous in molecular and biological properties and remained sensitive to penicillin antibiotics.

1. Chen, M. Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China / M. Chen, W. Yao, X. Wang et al. // Pediatr Infect Dis J. – 2012. – № 9. – P. e158–e162.

2. Guy, R. Increase in scarlet fever notifications in the United Kingdom, 2013/14 / R. Guy, C. Williams, N. Irvine et al. // Euro Surveill. – 2014. – № 12. – P.20749.

3. Lau, E.H. Scarlet fever outbreak, Hong Kong, 2011 / E.H. Lau, H. Nishiura, B.J. Cowling // Emerg Infect Dis. – 2012. – № 18. – P.1700–1702.

4. Kuzmina, N.N. Revmaticheskaya lihoradka: poluvekovoj opyt izucheniya problem. Razmyshleniya revmatologa [Tekst] / N.N. Kuzmina, L.G. Medynceva, B.S. Belov // Chelovek I lekarstvo – Kazahstan. – 2017. – № 2. – S. 125-137.

5. de Dassel, J.L. Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer? // J.L. de Dassel, A.P. Ralph, J.R. Carapetis // Curr Opin Pediatr. – 2015. – № 1. – P. 116-23.

6. Remenyi, B. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease / B. Remenyi, J. Carapetis, R. Wiber et al. // Nat Rev Cardiol. – 2013. – № 5. – P. 284–92.

7. Kuma, R.K. Rheumatic fever and rheumatic heart disease: the last 50 years / R.K. Kuma, R. Tandon // Indian J Med Res. – 2013. – № 4. – P. 643–58.

8. Nelson, G.E. Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012 / G.E. Nelson, T. Pondo, K.A. Toews et al. // Clin Infect Dis. – 2016. – № 4. – P. 478-86.

9. Meehan, M. Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013 / M. Meehan, S. Murchan, S. Bergin et al. // Euro Surveill. – 2013. – № 18. – P. 20556.

10. Olafsdottir, L.B. Invasive infections due to Streptococcus pyogenes : seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012 / L.B. Olafsdottir, H. Erlendsdottir, J. Melo-Cristino et al. // Euro Surveill. – 2014. – № 19. – P. 5– 14.

11. Briko, N. I. Scarlet fever [Tekst] / N. I. Briko // Meditsinskaya sestra. – 2012. – № 7. – S. 3-8.

12. Maniatis, T. Frich Eh. Sehmbruk D. Metody geneticheskoj inzheneri i molekulyarnoe klonirovanie [Tekst] / T. Maniatis, Eh. Frich, D. Sehmbruk // М., MIR. – 1984. – 480 s.

13. Briko, N.I. Chastota zabolevanij vyzvannyh streptokokkami gruppy A sredi invazivnyh infekcij myagkih tkanej I harakteristika vozbuditelya [Tekst] / N.I. Briko, A.G. Nosik, A.V. Dmitriev i dr. // ZHurn. Mikrobiol.-2014. – № 5. – S. 24-31.

14. Pokrovskij, V.I. Streptokokki i streptokokkozy [Tekst] / V.I. Pokrovskij, N.I Briko, L.A. Ryapis // M-gehotar-media. – 2006. – 544 s.

15. Kuzmina, N.N. Ostraya revmaticheskaya lihoradka u detej: 50-letnij opyt nablyudeniya (ot proshlogo – k budushchemu) [Tekst] / N.N. Kuzmina, L.G. Medynceva, G. R. Movsisyan // Nauchno-prakticheskaya revmatologiya. – 2010. – № 1. S. 9-14.

16. Stryuk, R.I. Revmaticheskie bolezni. Rukovodstvo dlya vrachej [Tekst] / R.I. Stryuk, L.M. Ermolina // M-binom. – 2014. – 588 s.

17. Singer, M. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) / M. Singer, C.S. Deutschman, C.W. Seymour // JAMA. – 2016. – № 8. – P. 801-810.

18. Briko, N.I. Vozmozhnost ehkcpress diagnostiki infekcij myagkih tkanej obuslovlennyh streptokokkami gruppy a chuvstvitelnost k antibiotikam I molekulyarno geneticheskie svojstva vozbuditelya [Tekst] / N.I. Briko, D.A. Klejmenov, N.F. Dmitrieva i dr. // Ehpidemiologiya i infekcionnye bolezni. -2015. – № 4. – S. 27-33.